AUCTORES
Globalize your Research
Case-Report | DOI: https://doi.org/10.31579/2641-0419/100
1Heart Failure Unit, Cardiovascular Research Centre, OLV Hospital Aalst, Moorselbaan 164, B-9300 Aalst, Belgium. 2Department of Pathology, OLV Hospital Aalst, Moorselbaan 164, B-9300 Aalst, Belgium.
*Corresponding Author: Marc Vanderheyden, Heart Failure Unit, Cardiovascular Research Centre, OLV Hospital Aalst, Moorselbaan 164, B-9300 Aalst, Belgium,
Citation: Sofie Dhaeyer., Chirik W, Lau., Vanessa Meert., Jan Leeman., Martin Penicka., Marc Vanderheyden., (2020) Angiosarcoma of the Heart: Case Report. J. Clinical Cardiology and Cardiovascular Interventions, 3(11); Doi:10.31579/2641-0419/100
Copyright: © 2020 Marc Vanderheyden, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 30 October 2020 | Accepted: 16 November 2020 | Published: 20 November 2020
Keywords: angiosarcoma; heart; primary cardiac tumors
Cardiac angiosarcomas are rare malignant tumors, predominantly affecting the right heart with poor survival outcomes. The current mainstay of treatment consists of surgery with or without chemotherapy, but often yields limited results with local relapse or metastatic recurrence.
This case report describes 2 patients with primary angiosarcoma located in the right atrium. One patient received neo-adjuvant and adjuvant chemotherapy; both were scheduled for surgical resection. The course of disease is described followed by a comprehensive review of the literature.
Primary cardiac tumors are extremely rare and are more frequently benign than malignant. [1] When malignant, the majority of them are lymphomas or sarcomas. [2] The Armed Forces Institute of Pathology Files reported 1 sarcoma among 533 primary cardiac tumors [3] and Burke et al [4] illustrated that of the 75 sarcomas diagnosed, 26 were angiosarcomas (35%). This case report describes 2 patients with primary angiosarcoma located in the right atrium. One patient received neo-adjuvant and adjuvant chemotherapy; both underwent surgical resection. The course of the disease is described followed by a comprehensive review of the literature.
Case presentation
Case 1
A 68-year old Caucasian man with no medical history was admitted with complaints of progressive dyspnea, anorexia, abdominal pain and headache for the past 6 months. Six months earlier when symptoms started, a tentative diagnosis of polymyalgia was made and methylprednisolone was initiated with initial good response. On admission he presented with signs of right heart failure with anasarca edema, ascites and elevated central venous pressure. Abdominal ultrasound confirmed the presence of ascites, however without apparent signs of liver disease. Unexpectedly it also demonstrated an intracardiac mass which, on transoesophageal echocardiography (TOE), revealed to be a floating multilocular mass originating from the lateral wall of the right atrium responsible for a vena cava syndrome with obstruction of the tricuspid valve (Figure 1A).
Interestingly this mass was not present on a transthoracic echocardiogram (TTE) performed 9 months earlier. On cardiac CT and MRI, the intracardiac mass with a maximal diameter of 11.5 cm was highly vascularized. Furthermore, pericardial invasion, encasement of the right coronary artery and a large subcarinal lymph node were seen. On PET-CT, high fluoro-18-deoxyglucose (FDG) uptake was observed at the level of the right atrium and the area around as well as in two spots on the left oropharynx and left humeral head (Figure 2).
These 2 hot spots were related to an inclusion cyst and arthrosis of the shoulder. Arguments for metastasis were absent. Histological and immunohistochemical analysis of tissue obtained by a transfemoral biopsy showed infiltrative blood vessels with atypical cells staining positive for ERG, CD31 with a Ki-67 proliferation index of 50%, compatible with the diagnosis of angiosarcoma (Figure 3).
The clinical staging of the tumor was cT2b cN1 M0. To downsize the tumor and facilitate surgical resection neoadjuvant chemotherapy with 3-weeks of treatment with paclitaxel followed by 1 week of rest for 12 cycles was initiated. Re-evaluation after 6 cycles showed good clinical response with significant echocardiographic regression (Figure 1B). Surgery was proposed and will be planned after completion of the chemotherapy (cfr discussion)
Case 2
An 88-year old Caucasian man with a past history of mitral valve annuloplasty (Carpentier-Edwards Physio II ring) was admitted with complaints of general discomfort, anorexia and dyspnea. He had been treated with antibiotics for a bronchial infection, though without any clinical improvement. On presentation, tachycardia (atrial fibrillation) and low oxygen saturations were noted with signs of left sided congestive heart failure with bilateral pleural effusion on chest X-ray and an elevated serum NT-proBNP. He was admitted with a tentative diagnosis of acute decompensated heart failure triggered by recent respiratory infection and new onset atrial fibrillation.
Transthoracic echocardiography revealed a right atrial mass with a diameter of 7.3 cm (Figure 4).
Similar to the previous case a TTE obtained thirteen months before showed no atrial mass. On MRI the mass originated from the interatrial septum of the right atrium with a signal intensity suggestive of a myxoma, although a sarcoma could not be ruled out (Figure 5).
Additional PET-CT showed low FDG uptake of the atrial mass, metastatic disease could not be detected (Figure 5). Under extracorporeal circulation the mass was resected, and the interatrial septum was reconstructed with a bovine pericardium patch. Anatomopathological examination revealed the mass to be an angiosarcoma, with positive staining for CD31 and Ki-67(Figure 6).
Although the resection margins were not tumor-free, no adjuvant chemotherapy was given because of patient’s advanced age and general condition. Six weeks following surgery he was readmitted because of progressive dyspnea due to a massive right sided pleural effusion. Three liters of fluid were evacuated. Histological examination of the fluid didn’t show atypical or malignant cells, nor signs of tumor recurrence. Despite these reassuring findings relapsing pleural effusions occurred, ultimately treated by a thoracoscopic pleurodesis. Four months after surgery the patient presented with cachexia and abdominal ultrasound showed liver metastasis. Considering the advanced age, frailty and expected prognosis, he was referred for palliative care.
Sarcomas, particularly the angiosarcomas, are vascular in origin and typically reside in the right-sided structures of the heart with predilection for the right atrium. [5] They often occur in a young age population, but as observed in the second patient have also been described in any age-group. Frequent presenting symptoms include dyspnea (44% of the patients), chest pain (8%) or shortness of breath, attributed to pleural effusion (28%). [2]
Cardiac angiosarcoma is defined by endothelial differentiation and characterized by a high proliferation rate, permeating and destructive nature, propensity to metastasize, and poor prognosis with patients succumbing to disease within a few months of diagnosis. Molecular aberrations detected in cardiac angiosarcoma often involve KDR and KIT and homozygous deletion of CDKN2A. The presence of somatic mutations in angiogenic signaling pathways, provides a rationale for investigating targeted therapies. [5]
As cardiac angiosarcomas are extremely rare, evidence-based therapeutic guidelines are lacking and most therapeutic strategies are based on retrospective studies and case reports. Ultimately the cornerstone of every treatment plan with curative intent remains complete R0 surgical resection, defined as macro- and microscopical tumor free resection margins. Whenever possible, this results in a median survival of 17-53.5 months vs 6-9.1 months for those in whom resection is incomplete. [6,7] As the tumor often grows into critical structures such as the tricuspid valve, not only the location but also its relationship with the surrounding structures determines the type of surgery. In this regard two identical cases to our first one with encasement of the right coronary artery and tumor growth into the tricuspid valve apparatus have been described where tumor, RCA and tricuspid valve were completely resected followed by replacement of the tricuspid valve and reconstruction of the right atrioventricular wall with bovine pericardium. Though grafting of the RCA happened only in one of the two cases, both patients had a good right ventricular function postoperatively. [8,9] Although initial successful, the first patient died of metastasis 10 months after the surgery. The second patient survived 12 months without metastasis. No further data were registered. Hirose K et al. described a similar case with complete resection of an angiosarcoma invading the right ventricular wall close to the tricuspid valve. Nevertheless, also this patient died three months later due to pulmonary metastasis in absence of local recurrence. [10]
In those with tumors located in the left atrium, heart transplantation can be an option. However even for these patients the prognosis remains poor with a median survival time of 9 months after heart transplantation, one month longer than the survival reported after palliative therapies. [11,12]
Other therapeutic modalities such as chemo- and radiotherapy have been explored with intention to downsize the tumor and increasing the odds for a complete surgical resection, as adjuvant treatment in case of metastasis or in a palliative setting. Anthracyclines, ifosfamide and paclitaxel are the chemotherapeutic agents of choice. [13] Large randomized trials evaluating the impact of chemotherapy on survival are scarce. The biggest trial evaluating the preoperative treatment with doxorubicin/ifosfamide to downsize the tumor, demonstrated a significant higher overall survival of 20 months compared to 9 months for those who only underwent surgery. [14] Similar outcome and effects on tumor reduction with less adverse effects and better tolerance have been reported for monotherapy with doxorubicin. [15] Also the retrospective ESPERO trial demonstrated a survival benefit for the group of patients who received neoadjuvant chemotherapy with either ifosfamide/adriamycine or gemcitabine/docetaxel. [6]
In patients with metastatic disease, similar chemotherapeutical agents have been used in combination with surgical resection. Experimental as well as clinical studies with combination therapy with doxorubicin/cyclophosphamide/vincristine as well as paclitaxel with or without doxorubicin have demonstrated a positive impact on the metastatic spread of the tumor and survival. [16-19]
Recently the role of immunotherapy has been investigated. It has been shown that patients receiving combination therapy with doxorubicin and olaratumab (26.5 months) as well as patients on a combination therapy with doxorubicin and olaratumab (14.3months) had a better prognosis compared to placebo/standard therapy. [19,20]
As KDR and VEGDR2, both markers of angiogenesis and vasculogenesis, are highly expressed in angiosarcomas and somatic mutations in angiogenic signaling pathways are often observed [5], molecules inhibiting vasculogenesis such as initinib, lenvatinib, pazopanib, regorafenib, vatalanib, and tivozanib are good candidates for targeted therapy. [22] In this regard, the PALETTE trial, comparing pazopanib to placebo in soft-tissue angiosarcoma, showed significant benefit for progression-free survival of pazopanib. [23]
Finally, also radiation therapy combined with surgery and/or chemotherapy can be an option. However, high radiation doses with direct cardiotoxic effect are often needed due to technical challenges related to the movement of the tumor. Newer technologies such as breath-hold sequences, intensity-modulated radiotherapy tracing and four-dimensional tumor analysis are under development in an attempt to overcome these challenges. [24]
Conclusions
Cardiac angiosarcomas are rare neoplasms, predominantly affecting the right heart. With scarce evidence from literature the current mainstay of treatment is complex an consists of surgery with or without chemotherapy. Outcome remains very poor. Therefore, there is an urgent need of more adequate tools for early diagnosis and more effective treatment.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
